-3%

est. 2Y upside i

Data & Analytics

Automated data pipeline and ELT platform for cloud data warehouses

Rank

#3628

Sector

Data Integration, Analytics, SaaS

Est. Liquidity

~3Y

Data Quality

Data: Medium

Fivetran is a category-defining business with $325M ARR growing 33% YoY and marquee enterprise customers, but the $12.79B secondary valuation (39.4x ARR) is priced well above where comparable data infrastructure companies trade publicly (8-15x ARR), embedding a significant multiple-compression headwind even in a strong growth scenario.

Last updated: May 5, 2026

Bull (20%)+40%

The all-stock dbt Labs merger closes on schedule and delivers a unified $1B+ ARR data infrastructure platform by 2028, attracting an IPO at 18-20x ARR on the combined entity (~$18-20B total). Fivetran shareholders (holding ~75% of combined equity) see roughly +40% appreciation versus the current $12.79B secondary price, with the AI data-movement boom serving as the primary demand catalyst.

Base (50%)0%

The merger closes but integration absorbs 12-18 months of management focus; combined ARR reaches ~$850M by 2028 growing ~22% YoY. Secondary market stabilizes near current $12-13B as revenue growth roughly offsets gradual multiple compression toward public-market comparables (12-15x ARR), leaving employee equity roughly flat over the 2-year horizon.

Bear (30%)-38%

Integration friction drives customer churn and a slowing sales cycle; cloud-native alternatives from AWS, Google, and Azure capture mid-market connector share. The secondary market marks down to $8-9B as IPO prospects recede and the company draws on its $125M debt facility, with common shareholders absorbing a full -38% haircut from the $12.79B entry price.

Est. time to liquidity~2.5 years

Preference Stack Risk

moderate

Funding Intensity

660%

Total funding of $849M against a $12.79B current valuation equals a 6.6% preference overhang—within the moderate 5-15% band—meaning common stockholders retain meaningful proceeds in exits at or above current valuation, but a down-round to below ~$5-6B would begin to impair common stock.

Dilution Risk

high

The pending all-stock merger with dbt Labs will issue new Fivetran shares to dbt shareholders, reducing existing common-holder ownership by an unknown but potentially significant percentage on top of $849M in prior funding rounds.

Secondary Liquidity

moderate

An active secondary market is reflected in the $12.79B April 2026 implied valuation, but individual employee transfers typically require company approval and may be limited to company-sponsored tender offers or approved secondary platforms.

Other — 168 roles

View all 168 open roles at Fivetran →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Fivetran's data — designed to show you've done your homework.

  • 1

    “With the all-stock dbt Labs merger expected to close within months, how is leadership prioritizing integration and what specific milestones define success in year one post-close—and how does this affect the combined entity's IPO timeline?”

  • 2

    “Usage-based MAR pricing gives customers direct control over spend; what floor does the subscription tier provide, and how has net revenue retention trended as enterprise buyers became more cost-conscious post-2023?”

  • 3

    “Given that new grants will be issued near the $12.79B secondary valuation, what is the latest 409A fair market value relative to that secondary price, and how will the dbt merger affect the strike price or conversion terms for my specific equity grant?”

Community

Valuation Sentiment

Our model estimates -3% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.